An intracranial aneurysm is an unusual swelling of the wall of an artery, which is a type of blood vessel carrying blood to the brain. The aneurysm is like a small sac and is localized, meaning it is limited to a small area, within the artery. Aneurysms can enlarge and compress normal structures inside the head.

They can also break, allowing blood to discharge from the blood vessel, under high pressure, into the fluid-containing space around the brain, or even straight into the brain tissue. Aneurysms can be treated by endovascular coil treatment – placing a small coil or coils inside the aneurysm through a catheter, a thin plastic tube, inside the artery, or the placement of a clip outside the aneurysm.

Market Dynamics

Increasing regulatory approvals for interventional intracranial aneurysm treatment devices, is expected to drive the growth of global interventional intracranial aneurysm devices market. For instance, on April 6, 2022, Aidoc, the leading provider of healthcare AI solutions based in Israel, announced that it had received U.S. Food and Drug Administration 510(k) clearance for AI-driven brain aneurysm triage and notification. This new solution now alerts the user about probable positive brain aneurysm occurrences. Aidoc states that the brain aneurysm solution provides a care coordination workflow for radiologists, neuroendovascular surgeons, and neurologists who treat many and different types of patients in a diverse locations.

The increasing number of surgeries in the region is expected to drive the market growth of global interventional intracranial aneurysm devices market over the forecast period. For instance, according to an article published by the International Journal of Surgery, a peer-reviewed medical journal of surgery, in May 2021, an online national cross-sectional survey was conducted in September-November 2020, involving elements from recognized surgical and anesthesia facility assessment tools to assess infrastructure, workforce, and availability of resources across Ethiopian government facilities. According to the survey, the number of surgeries per 100,000 people in Ethiopia was 465 in 2019, which was a >10-fold increase from the surgeries in 2012.

Increasing prevalence of hypertension, which in turn can lead to intracranial aneurysm, is expected to drive the growth of global interventional intracranial aneurysm devices market, over the forecast period. For instance, according to an article published by the Bentham Science Publishers, a science, technology, and medical publisher, in September 2020, in Latin America, hypertension prevalence varies from 30% to 50%. The principal factors linked to a higher risk of hypertension in Latin America are increased adiposity, low muscle strength, unhealthy diet, low physical activity, and low awareness.

Key features of the study:

• This report provides an in-depth analysis of the global interventional intracranial aneurysm devices market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global interventional intracranial aneurysm devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include MicroPort Scientific Corporation, B. Braun SE, Stryker, MicroVention Inc., Johnson & Johnson Private Limited, Terumo Corporation, Penumbra, Inc., KANEKA CORPORATION, Perflow Medical Ltd, phenox GmbH, Evasc, ASAHI INTECC CO., LTD., Acandis GmbH, Imperative Care, Medtronic
• Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global interventional intracranial aneurysm devices market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global interventional intracranial aneurysm devices market

Detailed Segmentation:

• Global Interventional Intracranial Aneurysm Devices Market, By Procedure Type:
  • Aenurysm Coil Embolization
  • FD Placement
  • Overmolded Stent Carrying Artery Occlusion
  • Other Procedures (Surgical Clipping, etc.)
• Global Interventional Intracranial Aneurysm Devices Market, By Intracranial Aneurysm Type:
  • Saccular Aneurysm
  • Fusiform Aneurysm
  • Others (Mycotic aneurysms, etc.)
• Global Interventional Intracranial Aneurysm Devices Market, By End User:
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
• Global Interventional Intracranial Aneurysm Devices Market, By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • U.K.
      • Germany
      • Italy
      • Spain
      • France
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country:
      • Australia
      • India
      • China
      • Japan
      • ASEAN
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • MicroPort Scientific Corporation *
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Braun SE
  • Stryker
  • MicroVention Inc.
  • Johnson & Johnson Private Limited
  • Terumo Corporation
  • Penumbra, Inc.
  • KANEKA CORPORATION
  • Perflow Medical Ltd
  • phenox GmbH
  • Evasc
  • ASAHI INTECC CO., LTD.
  • Acandis GmbH
  • Imperative Care
  • Medtronic

“*” marked represents similar segmentation in other categories in the respective section.